Tech Company Inital Public Offerings

Insulet IPO

Operating out of Bedford, Insulet is now a public company.

Transaction Overview

Company Name
Announced On
5/16/2007
Transaction Type
IPO
Amount
$120,000,000
Proceeds Purpose
Proceeds purposes are detailed in the company's filing statements with the SEC.

Company Information

Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
9 Oak Park Dr.
Bedford, MA 01730
USA
Email Address
Overview
Insulet Corporation (Nasdaq: PODD), located in Bedford, Massachusetts, is an innovative diabetes management company dedicated to providing superior treatment options and lifelong health benefits to people with diabetes.
Profile
Insulet LinkedIn Company Profile
Social Media
Insulet Company Twitter Account
Company News
Insulet News
Facebook
Insulet on Facebook
YouTube
Insulet on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Duane DeSisto
  Duane DeSisto LinkedIn Profile  Duane DeSisto Twitter Account  Duane DeSisto News  Duane DeSisto on Facebook
Chief Financial Officer
Brian Roberts
  Brian Roberts LinkedIn Profile  Brian Roberts Twitter Account  Brian Roberts News  Brian Roberts on Facebook
VP - General Counsel
Anthony Diehl
  Anthony Diehl LinkedIn Profile  Anthony Diehl Twitter Account  Anthony Diehl News  Anthony Diehl on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/15/2007: Finsbury Solutions Limited venture capital transaction
Next: 5/16/2007: ID Analytics venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary